4 Apr En este trabajo se empleó la alfa-fetoproteína (AFP) por hepatitis C. Este marcador tumoral mostró una sensibilidad de % y una. 11 Dec. A dosagem de alfa-feto proteína, inicialmente descrita por Abelev, et al.1 em, é o mais difundido marcador tumoral empregado para rastreamento e. 24 May. A dosagem de alfa-feto proteína, inicialmente descrita por Abelev, et al.1 em , é o mais difundido marcador tumoral empregado para rastreamento e.

Author: Voodoomuro Vumi
Country: Indonesia
Language: English (Spanish)
Genre: Video
Published (Last): 26 April 2011
Pages: 463
PDF File Size: 1.13 Mb
ePub File Size: 7.67 Mb
ISBN: 532-2-56537-499-1
Downloads: 73715
Price: Free* [*Free Regsitration Required]
Uploader: Kektilar

Toggle navigation Toggle search ClipReview. This is the pattern typical of geographic areas where HBV infection is not endemic The remaining etiologies for HCC in this group were alcoholic HC and cryptogenic cirrhosis, with four Model for end-stage liver disease MELD score as a prognostic factor for postoperative morbidity and tumorao in cirrhotic patients undergoing hepatectomy for HCC.

East Afr Med J. Marker, tumor Marker, tumor: Unidad de Medicina Paliativa.

This is a better outcome than that reported by Nguyen et al. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma.


The AFP determinations were performed during the first evaluation visit of the patient, and then every 6 marcwdor. Medical Dictionary Marker, tumor Marker, tumor: Enhanced detection of hepatocellular carcinoma. Eur J Int Med. High alphafetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: These data are similar to those reported in countries with low prevalence and incidence rates of HBV 11, A systematic review and critical analysis.


J Formos Med Assoc. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Viral hepatitis was the main cause of HC, with 83 cases Most markers also have a prognostic marcdaor at the time of diagnosis, since their concentration is related to tumor size.

Extensive screening for occult malignant disease in idiopathic venous thromboembolism: Demonstration of alpha-fetoprotein in serum of healthy human adults. Eur J Intern Med. The results of this study are conformed to our expectations. The exclusion criteria were pregnancy, antecedents of other neoplasias and refusal of the patient to enter the study.

Bruix J, Sherman M. Liver transplantation for hepatocellular cancer: J Compot Assist Tomogr.

Valor diagnóstico de la alfa-fetoproteína en el carcinoma hepatocelular

The results coincide with previous reports investigating the influence of viral infections on AFP concentrations. A diagnosis of HC was established by compliance with at least one of the following criteria: Our aim is to review the tumor markers most commonly used in our clinical practice, as well as some agreed recommendations on the indication of their determination in various tumors.

Consultado 02 Ene In all, 22 patients The HCC diagnosis took into account the criteria established by the European Association for the Study of Liver Disease EASLD for patients with HC and tumoral lesions larger than 2 cm, which produce a typical pattern of hypervascularization for imagenological techniques According to the available statistical data, it is the main cause of death in people with compensated hepatic cirrhosis HCand variously alternates between the fifth and sixth position, according to the country, as the most frequent neoplasia to new cases worldwide per year.


Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. Bruix J, Llovet JM. This investigation demonstrated the presence of HCC in El hallazgo de concentraciones elevadas de cualquier marcador, de forma aislada, tiene un valor limitado.

Development of a radioimmunoassay for alpha-fetoprotein. Histological typing of tumours in the liver. Clinical alfacetoproteina of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.

Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Major achievements in hepatocellular carcinoma. The investigations examining the usefulness of AFP as a screening and surveillance tool have not been directly comparable: